Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Trial of STAHIST in Seasonal Allergic Rhinitis

ClinicalTrials.gov ID: NCT01293201

Public ClinicalTrials.gov record NCT01293201. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 7:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of STAHIST in Adult and Adolescent Subjects With a History of Seasonal Allergic Rhinitis

Study identification

NCT ID
NCT01293201
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Magna Pharmaceuticals, Inc.
Industry
Enrollment
290 participants

Conditions and interventions

Interventions

  • STAHIST Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
May 31, 2011
Completion
Jul 31, 2011
Last update posted
Sep 1, 2011

2011

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Clinical Research Atlanta Stockbridge Georgia 30281
The South Bend Clinic South Bend Indiana 46617
Family Allergy and Asthma Institute Louisville Kentucky 40215
Family Allergy and Asthma Somerset Kentucky 42501
New Horizons Clinical Research Cincinnati Ohio 45242
National Allergy, Asthma & Urticaria Centers of Charleston, PA Charleston South Carolina 29406
Pharmaceutical Research and Consulting, Inc Dallas Texas 75231
Central Texas Health Research New Braunfels Texas 78130

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01293201, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2011 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01293201 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →